ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,202.00
      -0.39%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.805
      0.32%
      Bitcoin
      62,606.78
      -0.39%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ATAI Life Sciences NV (ATAI)

      7. ATAI Life Sciences NV (ATAI) News

      ATAI

      ATAI Life Sciences NV (ATAI)

      ATAI Life Sciences NV
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATAI
      DateTimeSourceHeadlineSymbolCompany
      03/30/20235:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATAIATAI Life Sciences NV
      03/24/20236:59AMGlobeNewswire Inc.atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline HighlightsNASDAQ:ATAIATAI Life Sciences NV
      03/06/20237:00AMGlobeNewswire Inc.atai Life Sciences Announces Key Clinical Pipeline and Corporate UpdatesNASDAQ:ATAIATAI Life Sciences NV
      03/01/20234:01PMGlobeNewswire Inc.atai Life Sciences to Participate in the Cowen 43rd Annual Health Care ConferenceNASDAQ:ATAIATAI Life Sciences NV
      02/10/20238:40AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ATAIATAI Life Sciences NV
      01/09/20236:59AMGlobeNewswire Inc.atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from Phase 1 Single and Multiple Ascending Dose Trial of GRX-917NASDAQ:ATAIATAI Life Sciences NV
      01/06/20237:00AMGlobeNewswire Inc.atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant DepressionNASDAQ:ATAIATAI Life Sciences NV
      12/23/20226:59AMGlobeNewswire Inc.atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101NASDAQ:ATAIATAI Life Sciences NV
      12/19/20226:38PMDow Jones NewsADRs End Mixed; AstraZeneca, atai Life Sciences Trade ActivelyNASDAQ:ATAIATAI Life Sciences NV
      12/19/20226:59AMGlobeNewswire Inc.atai Life Sciences Initiates Phase 2b proof-of-concept trial of RL-007 for Cognitive Impairment Associated with SchizophreniaNASDAQ:ATAIATAI Life Sciences NV
      12/16/202210:00AMGlobeNewswire Inc.The atai Fellowship Fund in Psychedelic Neuroscience Announces its First Cohort at Massachusetts General HospitalNASDAQ:ATAIATAI Life Sciences NV
      11/29/20226:59AMGlobeNewswire Inc.atai Life Sciences Strengthens Leadership Team with Appointment of Dr. Sahil V. Kirpekar as Chief Business OfficerNASDAQ:ATAIATAI Life Sciences NV
      11/17/20227:16PMDow Jones NewsADRs End Mostly Higher, Alibaba and atai Life Sciences Trade ActivelyNASDAQ:ATAIATAI Life Sciences NV
      11/17/20227:00AMGlobeNewswire Inc.atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical Study Investigating Neuroplasticity Biomarkers in Treatment-Resistant Depression Patients Undergoing Ketamine TreatmentNASDAQ:ATAIATAI Life Sciences NV
      11/15/202211:45AMTipRanksMaxim Group Keeps Their Buy Rating on ATAI Life Sciences (ATAI)NASDAQ:ATAIATAI Life Sciences NV
      11/10/20228:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATAIATAI Life Sciences NV
      11/10/20227:57AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ATAIATAI Life Sciences NV
      11/10/20227:34AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATAIATAI Life Sciences NV
      11/10/20227:14AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATAIATAI Life Sciences NV
      11/10/20226:59AMGlobeNewswire Inc.atai Life Sciences Reports Third Quarter 2022 Financial Results and Business UpdateNASDAQ:ATAIATAI Life Sciences NV
      11/04/20229:35AMBusiness WireWomen in Psychedelics Announces atai as Platinum SponsorsNASDAQ:ATAIATAI Life Sciences NV
      11/01/20223:50PMAllPennyStocks.comBiotech Rips In Anticipation Of Q3 ResultsNASDAQ:ATAIATAI Life Sciences NV
      11/01/202212:00PMGlobeNewswire Inc.atai Life Sciences to Participate in November Investor Events & Healthcare ConferencesNASDAQ:ATAIATAI Life Sciences NV
      11/01/20227:00AMGlobeNewswire Inc.atai Life Sciences to Announce Third Quarter 2022 Financial Results and Business UpdateNASDAQ:ATAIATAI Life Sciences NV
      10/28/20226:15AMTipRanksH.C. Wainwright Sticks to Their Buy Rating for ATAI Life Sciences (ATAI)NASDAQ:ATAIATAI Life Sciences NV
      10/25/20226:42PMDow Jones NewsADRs End Mostly Higher, AstraZeneca and atai Life Sciences Trade ActivelyNASDAQ:ATAIATAI Life Sciences NV
      10/25/20227:03AMGlobeNewswire Inc.atai Life Sciences Company, Perception Neuroscience, Completes Enrollment for Phase 2a Clinical Trial of PCN-101 (R-Ketamine) for Treatment-Resistant DepressionNASDAQ:ATAIATAI Life Sciences NV
      10/20/20226:59AMGlobeNewswire Inc.atai Life Sciences Announces R&D Day AgendaNASDAQ:ATAIATAI Life Sciences NV
      10/18/20227:00AMGlobeNewswire Inc.atai Life Sciences Announces Initiation of Phase 1 Proof-of-Concept Clinical Trial for Its Sol-gel Based Direct-to-Brain Drug Delivery TechnologyNASDAQ:ATAIATAI Life Sciences NV
      10/14/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATAIATAI Life Sciences NV
       Showing the most relevant articles for your search:NASDAQ:ATAI